CompletedNCT00095433
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
PHASE3 · 100 planned enrolment
- Countries listed
- 0
- Registry update
- March 26, 2014
Registry Intervention View
rhuFab V2 (ranibizumab)
Trial registrations containing the exact intervention label rhuFab V2 (ranibizumab).
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT00251459
A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
PHASE3 · 5,000 planned enrolment
- Countries listed
- 0
- Registry update
- March 10, 2014
CompletedNCT00090623
A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
PHASE3 · 180 planned enrolment
- Countries listed
- 1
- Registry update
- June 21, 2013